Vivani Medical, Inc. (VANI)
USD 0.99
(-0.01%)
USD 0.99
(-0.01%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -25.65 Million USD | -292.41% |
| 2022 | -6.53 Million USD | 46.12% |
| 2021 | -12.13 Million USD | -30.75% |
| 2020 | -9.27 Million USD | 72.38% |
| 2019 | -33.59 Million USD | 4.28% |
| 2018 | -35.09 Million USD | -23.07% |
| 2017 | -28.51 Million USD | 14.05% |
| 2016 | -33.17 Million USD | -65.75% |
| 2015 | -20.01 Million USD | 43.13% |
| 2014 | -35.2 Million USD | -53.26% |
| 2013 | -22.96 Million USD | -41.09% |
| 2012 | -16.27 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.03 Million USD | -0.22% |
| 2024 Q2 | -5.35 Million USD | 11.31% |
| 2023 Q2 | -6.52 Million USD | -8.14% |
| 2023 Q3 | -6.78 Million USD | -3.92% |
| 2023 Q1 | -6.03 Million USD | 11.24% |
| 2023 FY | -25.65 Million USD | -292.41% |
| 2023 Q4 | -6.02 Million USD | 11.15% |
| 2022 Q3 | 8.29 Million USD | 301.26% |
| 2022 Q1 | -3.94 Million USD | -8.87% |
| 2022 FY | -6.53 Million USD | 46.12% |
| 2022 Q4 | -6.79 Million USD | -182.01% |
| 2022 Q2 | -4.11 Million USD | -4.52% |
| 2021 Q3 | -3.49 Million USD | -52.18% |
| 2021 Q4 | -3.62 Million USD | -3.7% |
| 2021 Q1 | -2.98 Million USD | -131.37% |
| 2021 FY | -12.13 Million USD | -30.75% |
| 2021 Q2 | -2.29 Million USD | 23.2% |
| 2020 Q1 | -8.88 Million USD | -12.94% |
| 2020 Q4 | -1.29 Million USD | 19.46% |
| 2020 Q3 | -1.6 Million USD | 48.29% |
| 2020 Q2 | -3.1 Million USD | 65.11% |
| 2020 FY | -9.27 Million USD | 72.38% |
| 2019 Q1 | -9.7 Million USD | -9.51% |
| 2019 FY | -33.59 Million USD | 4.28% |
| 2019 Q4 | -7.86 Million USD | -3.74% |
| 2019 Q3 | -7.58 Million USD | 10.14% |
| 2019 Q2 | -8.44 Million USD | 12.99% |
| 2018 Q3 | -8.52 Million USD | -7.05% |
| 2018 FY | -35.09 Million USD | -23.07% |
| 2018 Q1 | -9.75 Million USD | -31.64% |
| 2018 Q2 | -7.96 Million USD | 18.37% |
| 2018 Q4 | -8.85 Million USD | -3.94% |
| 2017 FY | -28.51 Million USD | 14.05% |
| 2017 Q1 | -7.54 Million USD | 27.21% |
| 2017 Q2 | -6.84 Million USD | 9.34% |
| 2017 Q3 | -6.71 Million USD | 1.86% |
| 2017 Q4 | -7.4 Million USD | -10.32% |
| 2016 Q1 | -5.81 Million USD | -6.26% |
| 2016 FY | -33.17 Million USD | -65.75% |
| 2016 Q4 | -10.37 Million USD | -22.16% |
| 2016 Q3 | -8.48 Million USD | 0.18% |
| 2016 Q2 | -8.5 Million USD | -46.22% |
| 2015 Q1 | -4.95 Million USD | 63.49% |
| 2015 FY | -20.01 Million USD | 43.13% |
| 2015 Q2 | -4.92 Million USD | 0.69% |
| 2015 Q4 | -5.47 Million USD | -17.3% |
| 2015 Q3 | -4.66 Million USD | 5.21% |
| 2014 Q4 | -13.57 Million USD | -77.61% |
| 2014 Q2 | -7.54 Million USD | -17.12% |
| 2014 Q1 | -6.43 Million USD | -7.71% |
| 2014 FY | -35.2 Million USD | -53.26% |
| 2014 Q3 | -7.64 Million USD | -1.37% |
| 2013 Q2 | -5.36 Million USD | 1.48% |
| 2013 FY | -22.96 Million USD | -41.09% |
| 2013 Q1 | -5.44 Million USD | 0.0% |
| 2013 Q4 | -5.97 Million USD | 3.22% |
| 2013 Q3 | -6.17 Million USD | -15.1% |
| 2012 FY | -16.27 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 58.369% |
| BrainsWay Ltd. | -4.19 Million USD | -511.198% |
| Cerus Corporation | -37.48 Million USD | 31.575% |
| Envoy Medical, Inc. | -29.9 Million USD | 14.23% |
| electroCore, Inc. | -18.83 Million USD | -36.2% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -189.853% |
| IceCure Medical Ltd | -14.65 Million USD | -75.075% |
| Inogen, Inc. | -102.44 Million USD | 74.961% |
| OrthoPediatrics Corp. | -20.97 Million USD | -22.304% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 51.293% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -86.625% |
| MaxCyte, Inc. | -37.92 Million USD | 32.358% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -116.299% |
| Nexalin Technology, Inc. | -4.64 Million USD | -451.809% |
| Orthofix Medical Inc. | -151.39 Million USD | 83.056% |
| PAVmed Inc | -64.17 Million USD | 60.028% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 51.108% |
| RxSight, Inc. | -48.6 Million USD | 47.227% |
| Sight Sciences, Inc. | -55.54 Million USD | 53.819% |
| SI-BONE, Inc. | -43.33 Million USD | 40.807% |
| TELA Bio, Inc. | -46.66 Million USD | 45.028% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 48.206% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -88.854% |
| Acutus Medical, Inc. | -81.66 Million USD | 68.588% |
| Talis Biomedical Corporation | -62 Million USD | 58.63% |
| Spectral AI, Inc. | -20.85 Million USD | -23.008% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 57.793% |
| CVRx, Inc. | -41.19 Million USD | 37.736% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 4106.898% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -134.152% |
| Bioventus Inc. | -156.23 Million USD | 83.581% |
| Venus Concept Inc. | -37.25 Million USD | 31.136% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 56.55% |
| LivaNova PLC | 17.54 Million USD | 246.199% |
| 908 Devices Inc. | -36.39 Million USD | 29.526% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 86.256% |
| Nemaura Medical Inc. | -14.14 Million USD | -81.367% |
| NeuroPace, Inc. | -32.95 Million USD | 22.163% |
| LENSAR, Inc. | -14.38 Million USD | -78.349% |
| Apyx Medical Corporation | -18.71 Million USD | -37.081% |
| Cutera, Inc. | -162.83 Million USD | 84.246% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -136.861% |
| BioSig Technologies, Inc. | -29.04 Million USD | 11.67% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 68.969% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -16.13% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 137.868% |
| Axonics, Inc. | -6.08 Million USD | -321.353% |
| Outset Medical, Inc. | -172.79 Million USD | 85.155% |
| IRIDEX Corporation | -9.57 Million USD | -168.046% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 75.776% |
| IRadimed Corporation | 17.19 Million USD | 249.202% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -211.16% |
| INVO Bioscience, Inc. | -8.03 Million USD | -219.269% |
| Telesis Bio, Inc. | -47.72 Million USD | 46.249% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 350.434% |
| Varex Imaging Corporation | -47.7 Million USD | 46.222% |
| Quipt Home Medical Corp. | -2.78 Million USD | -821.408% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -127.29% |
| Pulmonx Corporation | -60.84 Million USD | 57.839% |
| Dynatronics Corporation | -2.69 Million USD | -850.877% |
| Modular Medical, Inc. | -17.47 Million USD | -46.835% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -125.274% |
| Semler Scientific, Inc. | 20.58 Million USD | 224.627% |
| InMode Ltd. | 197.91 Million USD | 112.961% |
| Bruker Corporation | 427.2 Million USD | 106.005% |
| Cytosorbents Corporation | -28.5 Million USD | 10.016% |
| DexCom, Inc. | 541.5 Million USD | 104.737% |
| Align Technology, Inc. | 445.05 Million USD | 105.764% |
| Viveve Medical, Inc. | -22.02 Million USD | -16.457% |
| ZimVie Inc. | -393.28 Million USD | 93.477% |
| Movano Inc. | -29.28 Million USD | 12.4% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -111.162% |
| Nexalin Technology, Inc. | -4.64 Million USD | -451.809% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 4106.898% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 88.477% |
| Profound Medical Corp. | -28.56 Million USD | 10.21% |
| Insulet Corporation | 206.3 Million USD | 112.434% |
| enVVeno Medical Corporation | -23.51 Million USD | -9.083% |
| Surmodics, Inc. | -11.54 Million USD | -122.249% |
| iCAD, Inc. | -4.84 Million USD | -429.235% |
| Nuwellis, Inc. | -20.2 Million USD | -26.934% |
| Biotricity, Inc. | -14.09 Million USD | -82.003% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 79.213% |
| Aethlon Medical, Inc. | -12.2 Million USD | -110.122% |
| InspireMD, Inc. | -19.91 Million USD | -28.801% |
| PAVmed Inc. | -64.17 Million USD | 60.028% |
| BIOLASE, Inc. | -20.63 Million USD | -24.331% |
| Beyond Air, Inc. | -60.24 Million USD | 57.418% |
| FONAR Corporation | 10.56 Million USD | 342.747% |
| AxoGen, Inc. | -21.71 Million USD | -18.125% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 189.96% |
| Inari Medical, Inc. | -1.63 Million USD | -1467.971% |
| UFP Technologies, Inc. | 44.92 Million USD | 157.101% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -399.812% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -288.36% |
| Tenon Medical, Inc. | -15.58 Million USD | -64.636% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -66.291% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 27.399% |
| AdaptHealth Corp. | -678.89 Million USD | 96.222% |
| Sintx Technologies, Inc. | -8.25 Million USD | -210.595% |
| NanoVibronix, Inc. | -3.71 Million USD | -591.242% |
| Quanterix Corporation | -32.33 Million USD | 20.666% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -127.29% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 5389.072% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 91.637% |
| TransMedics Group, Inc. | -25.02 Million USD | -2.493% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -15.899% |
| NeuroMetrix, Inc. | -6.52 Million USD | -292.864% |
| Hyperfine, Inc. | -44.23 Million USD | 42.014% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 67.323% |
| Biomerica, Inc. | -5.97 Million USD | -329.107% |
| Bone Biologics Corporation | -8.94 Million USD | -186.655% |
| AVITA Medical, Inc. | -39.16 Million USD | 34.508% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -157.708% |
| Silk Road Medical, Inc | -55.74 Million USD | 53.982% |